← Back to Search

Non-Invasive Brain Stimulation

Patients with BPD assigned to the trial of 10 active tDCS sessions followed by psychotherapy for Borderline Personality Disorder

N/A
Waitlist Available
Research Sponsored by Ciusss de L'Est de l'Île de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

A pilot study to examine the effects of Non-Invasive Brain stimulation on impulsive behaviour in patients diagnosed with Borderline Personality Disorder. patients who received the neurostimulation sessions will be enrolled in short term psychotherapy (3-month)

Eligible Conditions
  • Borderline Personality Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The effect of NIBS on impulsivity (UPPS- Behavioral Impulsive scale)
Secondary outcome measures
The Effect of tDCS on Risk taking ( an impulsive behavior dimension)
The effect of tDCS on BPD severity overall ( Borderline Personality Disorder Severity Index: BPDSI)
the effect of tDCS on depressive symptoms in BPD (Montgomery-Asberg Depression Rating Scale (MADRS))

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with BPD assigned to the trial of 10 active tDCS sessions followed by psychotherapyExperimental Treatment1 Intervention
Patients diagnosed with Borderline Personality disorder and BPDSI score is > or = 17 will be assigned for active tDCS session (NeuroConn, Germany) candidates will have 20-minute session per day for 10 weekdays in 2 weeks. Then they will attend short term psychotherapy session for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NeuroConn
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Dr. Lionel Cailhol, chef of psychiatry department at Montreal Psychiatric Institute (IUSMM)UNKNOWN
Ciusss de L'Est de l'Île de MontréalLead Sponsor
70 Previous Clinical Trials
5,547 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
403 Patients Enrolled for Borderline Personality Disorder
Dr. Lionel Cailhol, checf of psychiatry department at Montreal Psychiatric Institute (IUSMM)UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Kentucky
How old are they?
18 - 65
What site did they apply to?
Centre Recherche_ Institut Univesitaire de Santé Mentale à Montréal
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
The Effect of Non Invasive Brain Stimulation on Impulsivity in Borderline Personality Disorder
Ahmad Al Zatam 2021. "The Effect of Non Invasive Brain Stimulation on Impulsivity in Borderline Personality Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05453032.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top